|
|
Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress
|
|
|
|
|
نویسنده
|
qin z. ,freitas e. ,sullivan r. ,mohan s. ,bacelieri r. ,branch d. ,romano m. ,kearney p. ,oates j. ,plaisance k. ,renne r. ,kaleeba j. ,parsons c.
|
منبع
|
plos pathogens - 2010 - دوره : 6 - شماره : 1
|
چکیده
|
Upregulation of xct,the inducible subunit of a membrane-bound amino acid transporter,replenishes intracellular glutathione stores to maintain cell viability in an environment of oxidative stress. xct also serves as a fusion-entry receptor for the kaposi's sarcoma-associated herpesvirus (kshv),the causative agent of kaposi's sarcoma (ks). ongoing kshv replication and infection of new cell targets is important for ks progression,but whether xct regulation within the tumor microenvironment plays a role in ks pathogenesis has not been determined. using gene transfer and whole virus infection experiments,we found that kshv-encoded micrornas (kshv mirnas) upregulate xct expression by macrophages and endothelial cells,largely through mir-k12-11 suppression of bach-1 - a negative regulator of transcription recognizing antioxidant response elements within gene promoters. correlative functional studies reveal that upregulation of xct by kshv mirnas increases cell permissiveness for kshv infection and protects infected cells from death induced by reactive nitrogen species (rns). interestingly,kshv mirnas simultaneously upregulate macrophage secretion of rns,and biochemical inhibition of rns secretion by macrophages significantly reduces their permissiveness for kshv infection. the clinical relevance of these findings is supported by our demonstration of increased xct expression within more advanced human ks tumors containing a larger number of kshv-infected cells. collectively,these data support a role for kshv itself in promoting de novo kshv infection and the survival of kshv-infected,rns-secreting cells in the tumor microenvironment through the induction of xct.
|
|
|
آدرس
|
department of medicine,hollings cancer center,medical university of south carolina,charleston,sc,united states,department of craniofacial biology,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of dermatology,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of dermatology,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of pathology,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc,united states,medical service,ralph h. johnson va medical center,charleston,sc, United States, department of molecular genetics and microbiology,shands cancer center,university of florida,gainesville,fl, United States, department of molecular genetics and microbiology,shands cancer center,university of florida,gainesville,fl, United States, departments of microbiology and immunology and molecular/cell biology,uniformed services university of the health sciences,f. edward herbert school of medicine,bethesda,md, United States, department of medicine,hollings cancer center,medical university of south carolina,charleston,sc,united states,department of craniofacial biology,hollings cancer center,medical university of south carolina,charleston,sc, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|